Pavaki Capital Management LLC’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-328,100
Closed -$1.97M 171
2026
Q1
$1.97M Sell
328,100
-400,000
-55% -$3.01M 0.83% 26
2025
Q4
$5.22M Buy
+728,100
New +$5.75M 2.05% 11

Other funds holding OGN

Pavaki Capital Management LLC's OGN Position: Q2 2026 in Review

Pavaki Capital Management LLC sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 328,100 shares — an estimated $1.97M sold.

Pavaki Capital Management LLC first reported a position in OGN in Q4 2025 and held it in 2 quarters. The position peaked at $5.22M in Q4 2025. 330 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Pavaki Capital Management LLC reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
  • Pavaki Capital Management LLC sold 328,100 Organon & Co shares in Q2 2026, an estimated $1.97M.
  • Pavaki Capital Management LLC first reported a position in Organon & Co in Q4 2025 and held it in 2 quarters.
  • Pavaki Capital Management LLC's Organon & Co position peaked at $5.22M in Q4 2025.
  • 330 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Pavaki Capital Management LLC's 13F filing for Q2 2026, filed 7 Aug 2026.